- Business Wire•3 days agoNeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call
NeuroMetrix, Inc. announced today that it plans to issue its 2016 full year and fourth quarter financial results before the opening of the market on January 26, 2017.
- Business Wire•13 days ago
NeuroMetrix, Inc. reported Q4 2016 demand highlights for its Quell® Wearable Pain Relief Technology™. During Q4 2016 the invoiced value of Quell shipments totaled approximately $3.5 million, an increase of 19% from $2.9 million reported in Q3 2016.
- Business Wire•17 days agoNeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine
NeuroMetrix, Inc. today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Digital Medicine Showcase 2017 at the Parc 55 San Francisco in San Francisco, CA. The Digital Medicine Showcase brings together innovative companies showcasing clinically impactful digital health technologies, venture capital and private equity investors, pharma executives ...
NURO : Summary for NeuroMetrix, Inc. - Yahoo Finance
NeuroMetrix, Inc. (NURO)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.02 x 600|
|Ask||1.50 x 100|
|Day's Range||0.68 - 0.71|
|52 Week Range||0.60 - 2.36|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.07|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|